Presentation: Parvesh Kumar

Parvesh Kumar, (Medicine) presented his research findings at the 2016 annual meeting of the American Society of Radiation Oncology (ASTRO) in Boston. The research co-authored by Dr. Kumar highlights Phase 1 -2 cancer trials to determine if a three-pronged treatment for patients undergoing radical prostatectomy (the removal of the prostate gland and surrounding tissue) for certain types of high-risk prostate cancer was safe, tolerable, and effective. The trial results showed the trimodal approach, which comprises radiation therapy, concurrent drug therapy (docetaxel), and hormone therapy, is safe, well tolerated and has a high feasibility rate for these types of patients.

He also presented at the 54th annual meeting of the Japan Society of Clinical Oncology in Yokohama, Japan. He discussed how the treatment of locally advanced head and neck cancer is moving toward precision-targeted medicine, which is personalized for each individual patient. He was one of only three U.S. radiation oncologists invited to present at the conference. The other two researchers were from Harvard Medical School. 

People in the News

People | June 5, 2020
How a classroom assignment led UNLV alumna Jessica Walters Murrey to a career as a social change communication expert.
Portrait of Dr. Daniel Diaz wearing blue scrubs. Diaz is playing a key role in day-to-day operations at UNLV Medicine's COVID-19 curbside test operation
People | June 1, 2020
A spate of childhood sports injuries first led Diaz to medical school and now to a sports medicine fellowship at UNLV.
UNLV student with engineering building in background
People | May 28, 2020
Engineer’s research on improved flood control for Las Vegas led to a flood of research publications and a bright future.